Mandatory review of a prescription drug monitoring program and impact on opioid and benzodiazepine dispensing

被引：73

作者：

Winstanley, Erin L. ^{[1
]}

Zhang, Yifan ^{[2
]}

Mashni, Rebecca ^{[3
]}

Schnee, Sydney ^{[4
]}

Penm, Jonathan ^{[5
]}

Boone, Jill ^{[6
]}

McNamee, Cameron ^{[7
]}

MacKinnon, Neil J. ^{[6
]}

机构：

[1] West Virginia Univ, Sch Med, Dept Behav Med & Psychiat, 930 Chestnut Ridge Rd, Morgantown, WV 26505 USA

[2] West Virginia Univ, Sch Pharm, POB 9500, Morgantown, WV 26506 USA

[3] Boston Univ, Sch Law, 765 Commonwealth Ave, Boston, MA 02215 USA

[4] Kroger Pharm, Springdale, OH USA

[5] Univ Sydney, Fac Pharm, Camperdown, NSW, Australia

[6] Univ Cincinnati, James L Winkle Coll Pharm, 3255 Eden Ave, Cincinnati, OH 45267 USA

[7] State Ohio Board Pharm, 77 S High St, Columbus, OH 43215 USA

来源：

DRUG AND ALCOHOL DEPENDENCE | 2018年 / 188卷

基金：

美国国家卫生研究院;

关键词：

Prescription opioids; Policy; Benzodiazepines; Dispensing; PILL MILL LAWS; UNITED-STATES; PAIN RELIEVERS; BEHAVIORS; OVERDOSES;

D O I：

10.1016/j.drugalcdep.2018.03.036

中图分类号：

R194 [卫生标准、卫生检查、医药管理];

学科分类号：

摘要：

Background: The purpose of this study is to determine whether Ohio House Bill 341, which mandated the use of Ohio's Prescription Drug Monitoring Program (PDMP), was an effective regulatory strategy to reduce opioid and benzodiazepine dispensing. Method: Secondary analysis of Ohio's PDMP data on prescription opioids and benzodiazepines dispensed from November 2014 to March 2017. An interrupted time series analysis was conducted to determine if there was a significant change in the quantity of opioids and benzodiazepines dispensed. Results: After HB341 became effective in April 2015, there was a statistically significant decrease in the monthly quantity (number of pills) opioids and benzodiazepines dispensed in Ohio. There was a modest increase in the mean days' supply of opioids and no change in the mean morphine equivalent dose. Conclusions: Legislation in Ohio requiring prescribers to check the PDMP was effective in reducing the quantity of opioids and benzodiazepines dispensed.

引用

页码：169 / 174

页数：6

共 32 条

[1]

[Anonymous], 2017, Ann Emerg Med, V70, P116, DOI 10.1016/j.annemergmed.2017.03.053

[2]

[Anonymous], 2017, BMJ, DOI DOI 10.1136/BMJ.J760

[3]

[Anonymous], 2014, BRIEF PDMP EFF

[4]

[Anonymous], 2013, Stata Statistical Software: Release 13

[5] Prescription Drug Monitoring Programs Are Associated With Sustained Reductions In Opioid Prescribing By Physicians [J].

Bao, Yuhua ;

Pan, Yijun ;

Taylor, Aryn ;

Radakrishnan, Sharmini ;

Luo, Feijun ;

Pincus, Harold Alan ;

Schackman, Bruce R. .

HEALTH AFFAIRS, 2016, 35 (06) :1045-1051

[6] Prescription Drug Monitoring and Dispensing of Prescription Opioids [J].

Brady, Joanne E. ;

Wunsch, Hannah ;

DiMaggio, Charles ;

Lang, Barbara H. ;

Giglio, James ;

Li, Guohua .

PUBLIC HEALTH REPORTS, 2014, 129 (02) :139-147

[7] Impact of New York prescription drug monitoring program, I-STOP, on statewide overdose morbidity [J].

Brown, Richard ;

Riley, Moira R. ;

Ulrich, Lydia ;

Kraly, Ellen Percy ;

Jenkins, Paul ;

Krupa, Nicole L. ;

Gadomski, Anne .

DRUG AND ALCOHOL DEPENDENCE, 2017, 178 :348-354

[8]

Burke J., 2016, PHARM TIMES

[9] Impact of prescription drug monitoring programs and pill mill laws on high-risk opioid prescribers: A comparative interrupted time series analysis [J].

Chang, Hsien-Yen ;

Lyapustina, Tatyana ;

Rutkow, Lainie ;

Daubresse, Matthew ;

Richey, Matt ;

Faul, Mark ;

Stuart, Elizabeth A. ;

Alexander, G. Caleb .

DRUG AND ALCOHOL DEPENDENCE, 2016, 165 :1-8

[10]

Clark Thomas., 2012, Prescription Drug Monitoring Programs: An Assessment of the Evidence for Best Practices

← 1 2 3 4 →